Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Glycoproteomic analysis of serum from patients with gastric precancerous lesions.

Gomes C, Almeida A, Ferreira JA, Silva L, Santos-Sousa H, Pinto-de-Sousa J, Santos LL, Amado F, Schwientek T, Levery SB, Mandel U, Clausen H, David L, Reis CA, Osório H.

J Proteome Res. 2013 Mar 1;12(3):1454-66. doi: 10.1021/pr301112x.

PMID:
23312025
2.
3.

[Prevalence of Helicobacter pylori infection and gastric cancer precursor lesions in patients with dyspepsia].

Muller LB, Fagundes RB, Moraes CC, Rampazzo A.

Arq Gastroenterol. 2007 Apr-Jun;44(2):93-8. Portuguese.

4.

[Difference analysis on proteome of Helicobacter pylori in patients with peptic ulcer, gastritis, and gastric cancer].

Zhang J, Ding SG, Zhong LJ, Lin SR, Yang B, Peng JR, Lou YX.

Zhonghua Yi Xue Za Zhi. 2006 Oct 17;86(38):2690-4. Chinese.

PMID:
17199978
5.

Serum peptide mapping in gastric precancerous lesion and cancer.

Li P, Ma D, Zhu ST, Tang XD, Zhang ST.

J Dig Dis. 2014 May;15(5):239-45. doi: 10.1111/1751-2980.12130.

PMID:
24438315
6.

Ectopic expression of guanylyl cyclase C and endogenous ligand guanylin correlates significantly with Helicobacter pylori infection in gastric carcinogenesis.

Zhang JF, Mao ZB, Li ZL, Xue SM, Zhu HJ, Zhang H, Ni RZ.

Med Oncol. 2012 Sep;29(3):1748-57. doi: 10.1007/s12032-011-0067-x.

PMID:
21972003
7.

Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.

Zhang L, Blot WJ, You WC, Chang YS, Kneller RW, Jin ML, Li JY, Zhao L, Liu WD, Zhang JS, Ma JL, Samloff IM, Correa P, Blaser MJ, Xu GW, Fraumeni JF Jr.

Cancer Epidemiol Biomarkers Prev. 1996 Aug;5(8):627-30.

8.

Immunoproteomics of Helicobacter pylori infection in patients with atrophic body gastritis, a predisposing condition for gastric cancer.

Lahner E, Bernardini G, Possenti S, Renzone G, Scaloni A, Santucci A, Annibale B.

Int J Med Microbiol. 2011 Feb;301(2):125-32. doi: 10.1016/j.ijmm.2010.06.006.

PMID:
20843738
9.

T (Thomsen-Friedenreich) antigen and other simple mucin-type carbohydrate antigens in precursor lesions of gastric carcinoma.

Carneiro F, Santos L, David L, Dabelsteen E, Clausen H, Sobrinho-Simões M.

Histopathology. 1994 Feb;24(2):105-13.

PMID:
8181802
10.

Gastric atrophy, metaplasia, and dysplasia: a clinical perspective.

Kapadia CR.

J Clin Gastroenterol. 2003 May-Jun;36(5 Suppl):S29-36; discussion S61-2. Review.

PMID:
12702963
11.

Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.

Giuliani A, Spada S, Corona M, Demoro M, Di Bari M, Ricciardulli T, Galati G, Caporale A, Tocchi A, Angelico F.

J Exp Clin Cancer Res. 2003 Sep;22(3):371-8.

PMID:
14582693
12.

Proteomics-based identification of a tumor-associated antigen and its corresponding autoantibody in gastric cancer.

Tsunemi S, Nakanishi T, Fujita Y, Bouras G, Miyamoto Y, Miyamoto A, Nomura E, Takubo T, Tanigawa N.

Oncol Rep. 2010 Apr;23(4):949-56.

PMID:
20204278
13.

K-ras mutations and cell kinetics in Helicobacter pylori associated gastric intestinal metaplasia: a comparison before and after eradication in patients with chronic gastritis and gastric cancer.

Watari J, Tanaka A, Tanabe H, Sato R, Moriichi K, Zaky A, Okamoto K, Maemoto A, Fujiya M, Ashida T, Das KM, Kohgo Y.

J Clin Pathol. 2007 Aug;60(8):921-6.

14.

Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.

Camorlinga-Ponce M, Flores-Luna L, Lazcano-Ponce E, Herrero R, Bernal-Sahagún F, Abdo-Francis JM, Aguirre-García J, Muñoz N, Torres J.

Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2498-504. doi: 10.1158/1055-9965.EPI-08-0289.

15.

Prevalence of Helicobacter pylori infection in patients with precancerous changes and gastric cancer.

Farinati F, Valiante F, Germanà B, Della Libera G, Baffa R, Rugge M, Plebani M, Vianello F, Di Mario F, Naccarato R.

Eur J Cancer Prev. 1993 Jul;2(4):321-6.

PMID:
8358284
16.

Association of polymorphisms in myeloperoxidase and catalase genes with precancerous changes in the gastric mucosa of patients at inner-city hospitals in New York.

Steenport M, Eom H, Uezu M, Schneller J, Gupta R, Mustafa Y, Villanueva R, Straus EW, Raffaniello RD.

Oncol Rep. 2007 Jul;18(1):235-40.

PMID:
17549373
17.

Proteomic identification of serum biomarkers for gastric cancer using multi-dimensional liquid chromatography and 2D differential gel electrophoresis.

Liu W, Liu B, Cai Q, Li J, Chen X, Zhu Z.

Clin Chim Acta. 2012 Jul 11;413(13-14):1098-106. doi: 10.1016/j.cca.2012.03.003.

PMID:
22446497
18.

Metabolomic phenotype of gastric cancer and precancerous stages based on gas chromatography time-of-flight mass spectrometry.

Yu L, Aa J, Xu J, Sun M, Qian S, Cheng L, Yang S, Shi R.

J Gastroenterol Hepatol. 2011 Aug;26(8):1290-7. doi: 10.1111/j.1440-1746.2011.06724.x.

PMID:
21443661
19.
20.
Items per page

Supplemental Content

Support Center